SIRT7 has since been linked to advanced tumor stages and high-histological grade tumors that metastasize to lymph nodes and distant sites and to worse prognosis and poor survival in breast (185, 186), liver (58, 187, 188), colorectal (189), pancreatic (191) and prostate (192, 193) cancers. Here, SIRT7 is linked to neoplasm.